000520.KS
Samil Pharmaceutical Co.,Ltd [000520.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000520.KS Stock Summary
Top 10 Correlated ETFs
000520.KS
Top 10 Correlated Stocks
000520.KS
In the News
000520.KS Financial details
Company Rating
-
Market Cap
208.12B
Income
1.66B
Revenue
196.35B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
548
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
42.44
Forward P/E
-
PEG
-0.07
P/S
0.63
P/B
0.83
P/C
-
P/FCF
-4.28
Quick Ratio
-
Current Ratio
0.57
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
120.79
EPS next Y
-
EPS next Q
-
EPS this Y
-5822.17%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.68%
Revenue last 5Y
10.15%
Revenue Q/Q
-2.16%
EPS Q/Q
-234.04%
-
-
-
-
SMA20
13.59%
SMA50
-0.47%
SMA100
3.48%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.01%
Gross Margin
37%
Oper. Margin
2%
Profit Margin
1%
Payout
3%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5690.0-12650.0
52W High
+3.48%
52W Low
+130.05%
RSI
60.17
Rel Volume
0.15
Avg Volume
748.62K
Volume
113.08K
Perf Week
7.56%
Perf Month
1.63%
Perf Quarter
-14.56%
Perf Half Y
-17.62%
-
-
-
-
Beta
0.277
-
-
Volatility
413.51%, 1044.7%
Prev Close
0.69%
Price
13090
Change
0.23%
Company Profile
- Volume Average 748.62K
- Market Capitalization 208.12B
- Employee 548
- CEO Mr. Kang Huh
- Headquarters Seoul,KR
- IPO Date 2000-01-04
-
Website
https://www.samil-pharm.com 
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
